Catalano M, et al. Sodium levels and outcomes in patients with metastatic renal cell carcinoma receiving nivolumab. JAMA Netw Open 2023; 6:e2345185. doi: 10.1001/jamanetworkopen.2023.45185
Schutz FA, et al. The impact of low serum sodium on treatment outcome of targeted therapy in metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Cancer Database Consortium. Eur Urol 2014; 65:723–730. doi: 10.1016/j.eururo.2013.10.013
Uppal NN, et al. Electrolyte and acid-base disorders associated with cancer immunotherapy. Clin J Am Soc Nephrol 2022; 17:922–933. doi: 10.2215/CJN.14671121
Workeneh BT, et al. Hyponatremia in the cancer patient. Kidney Int 2020; 98:870–882. doi: 10.1016/j.kint.2020.05.015